MT Receptor

亚型特异性产品

信号通路图

MT Receptor信号通路图

MT Receptor产品

  • 所有产品(4)
  • MT Receptor拮抗剂 (1)
  • MT Receptor激动剂 (3)
目录号 产品名 产品描述 文献引用 实验数据
S1204 Melatonin Melatonin是一种 MT receptor 激动剂激素, 用作膳食补充品。Melatonin 是一种选择性的 ATF-6 的抑制剂并可下调 COX-2。Melatonin 可增强线粒体自噬并调节凋亡和自噬的稳态。
Ecotoxicol Environ Saf, 2023, 255:114719
Microbiol Res, 2023, 276:127480
Cell Oncol (Dordr), 2023, 10.1007/s13402-023-00875-w
S1259 Ramelteon Ramelteon (TAK-375) 是一种新型的的Melatonin受体激动剂,作用于人MT1和MT2受体及小鸡前脑Melatonin受体,Ki值分别为14 pM, 112 pM和23.1 pM。
Aging Cell, 2021, e13375
Cell Cycle, 2021, 20(12):1195-1208
Plant Cell Physiol, 2020, 10.1093/pcp/pcaa018
S3584 Luzindole Luzindole (N-0774, N-acetyl-2-benzyltryptamine) 是一种选择性 褪黑激素受体(melatonin receptor) 拮抗剂,对MT1的Ki值为179 nM,对MT2的Ki值为7.3 nM。
Aging Cell, 2021, e13375
Int Immunopharmacol, 2021, 96:107787
S4281 Tasimelteon Tasimelteon (BMS 214778, VEC 162) is a selective dual melatonin receptor (MT1/MT2) agonist with 2.1-4.4 times greater affinity for the MT2 receptor believed to mediate circadian rhythm phase-shifting (Ki = 0.0692 nM and Ki = 0.17 nM in NIH-3T3 and CHOeK1 cells, respectively), than for the MT1 receptor (Ki = 0.304 nM and Ki = 0.35 nM, respectively).
Cells, 2022, 11(21)3467
S3584 Luzindole Luzindole (N-0774, N-acetyl-2-benzyltryptamine) 是一种选择性 褪黑激素受体(melatonin receptor) 拮抗剂,对MT1的Ki值为179 nM,对MT2的Ki值为7.3 nM。
Aging Cell, 2021, e13375
Int Immunopharmacol, 2021, 96:107787
S1204 Melatonin Melatonin是一种 MT receptor 激动剂激素, 用作膳食补充品。Melatonin 是一种选择性的 ATF-6 的抑制剂并可下调 COX-2。Melatonin 可增强线粒体自噬并调节凋亡和自噬的稳态。
Ecotoxicol Environ Saf, 2023, 255:114719
Microbiol Res, 2023, 276:127480
Cell Oncol (Dordr), 2023, 10.1007/s13402-023-00875-w
S1259 Ramelteon Ramelteon (TAK-375) 是一种新型的的Melatonin受体激动剂,作用于人MT1和MT2受体及小鸡前脑Melatonin受体,Ki值分别为14 pM, 112 pM和23.1 pM。
Aging Cell, 2021, e13375
Cell Cycle, 2021, 20(12):1195-1208
Plant Cell Physiol, 2020, 10.1093/pcp/pcaa018
S4281 Tasimelteon Tasimelteon (BMS 214778, VEC 162) is a selective dual melatonin receptor (MT1/MT2) agonist with 2.1-4.4 times greater affinity for the MT2 receptor believed to mediate circadian rhythm phase-shifting (Ki = 0.0692 nM and Ki = 0.17 nM in NIH-3T3 and CHOeK1 cells, respectively), than for the MT1 receptor (Ki = 0.304 nM and Ki = 0.35 nM, respectively).
Cells, 2022, 11(21)3467

MT Receptor抑制剂选择性比较

Tags: MT Receptor inhibitor|MT Receptor agonist|MT Receptor activator|MT Receptor inducer|MT Receptor antagonist|MT Receptor signaling pathway|MT Receptor assay kit
在线咨询
联系我们